Insulin-like growth factor-1 receptor activation prevents hydrogen peroxide-induced oxidative stress, mitochondrial dysfunction and apoptosis

Apoptosis. 2011 Nov;16(11):1118-27. doi: 10.1007/s10495-011-0634-9.

Abstract

Vascular disease is the leading cause of morbidity and mortality. Oxidative stress can cause endothelial cell apoptosis. Low insulin like growth factor-1 (IGF-1) has been linked to adverse risk profile and increased vascular disease incidence. Since IGF-1 acts as an important survival factor for multiple cell types, we undertook this study to investigate whether IGF-1 favorably affects oxidative-stress mediated apoptosis of vascular endothelial cells. Exposure to hydrogen peroxide induced apoptotic changes (e.g. DNA fragmentation, altered mitochondrial membrane potential and caspase-3 activity) in human umbilical vein endothelial cells (HUVECs) in a time dependent manner. Addition of IGF-1 blocked the oxidative-stress effect parallel to IGF-1 receptor (IGF-1R) expression, and silencing the IGF-1R with small interference RNA attenuated the IGF-1 influence. Our findings show that enhanced IGF-1 signaling inhibits oxidative-stress induced apoptosis in HUVECs by reducing mitochondrial dysfunction. Specifically the protective mechanism of IGF-1 involves preserving the mitochondrial membrane potential, maintaining the mitochondrial retention of cytochrome-c, and reducing caspase-3 activity. These results may have therapeutic implications in preventing/reducing vascular disease associated endothelial dysfunction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects
  • Caspase 3 / genetics
  • Caspase 3 / metabolism*
  • Caspase Inhibitors
  • Cells, Cultured
  • Cytochromes c / analysis
  • DNA Fragmentation / drug effects
  • Gene Silencing
  • Human Umbilical Vein Endothelial Cells / cytology
  • Human Umbilical Vein Endothelial Cells / drug effects*
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Humans
  • Hydrogen Peroxide / adverse effects
  • Hydrogen Peroxide / pharmacology
  • Insulin-Like Growth Factor I* / pharmacology
  • Membrane Potential, Mitochondrial / drug effects
  • Mitochondria / drug effects*
  • Mitochondria / metabolism
  • Oxidative Stress / drug effects
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / metabolism
  • Receptor, IGF Type 1 / antagonists & inhibitors
  • Receptor, IGF Type 1 / genetics
  • Receptor, IGF Type 1 / metabolism*
  • Signal Transduction / drug effects*
  • Vascular Diseases / drug therapy
  • Vascular Diseases / metabolism
  • Vascular Diseases / physiopathology
  • Vascular Diseases / prevention & control

Substances

  • Caspase Inhibitors
  • RNA, Small Interfering
  • Insulin-Like Growth Factor I
  • Cytochromes c
  • Hydrogen Peroxide
  • Receptor, IGF Type 1
  • Caspase 3